Phytanic acid: Measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids

British Journal of Nutrition

Volumn 99, Issue 3, 2008, Pages 653-659

  Allen, Naomi E ^a   Grace, Philip B ^b   Ginn, Annette ^b   Travis, Ruth C ^a   Roddam, Andrew W ^a   Appleby, Paul N ^a   Key, Timothy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LGC   (United Kingdom)

Author keywords

Dairy fat; Diet; EPIC Oxford; Measurement; Phytanic acid

Indexed keywords

PHYTANIC ACID; RACEMASE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CANCER RISK; CARNIVORE; CONTROLLED STUDY; DAIRY PRODUCT; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; GAS LIQUID CHROMATOGRAPHY; HUMAN; LIFESTYLE; MASS SPECTROMETRY; SMOKING; VEGETARIAN DIET;

ADULT; AGED; AGING; ANTHROPOMETRY; CROSS-SECTIONAL STUDIES; DAIRY PRODUCTS; DIET; DIET, VEGETARIAN; FATTY ACIDS; FEMALE; FOOD HABITS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIFE STYLE; MIDDLE AGED; PHYTANIC ACID;

ANIMALIA; SPONDIAS PURPUREA;

EID: 38949123070     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450782407X     Document Type: Article

References (33)

1. Armstrong B & Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15, 617-631.
2. Allen NE, Appleby PN, Davey GK & Key TJ (2000) Hormones and diet: Low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer 83, 95-97.
3. Gunnell D, Oliver SE, Peters TJ, et al. (2003) Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 88, 1682-1686.
4. Thornburg T, Turner AR, Chen YQ, Vitolins M, Chang B & Xu J (2006) Phytanic acid, AMACR and prostate cancer risk. Future Oncol 2 213-223.
5. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD & Gibberd FB (2002) Refsum's disease: A peroxisomal disorder affecting phytanic acid α-oxidation. J Neurochem 80, 727-735.
6. Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, L'Esperance BS, Jiang Z & Ho SM (2003) Branched fatty acids in dairy and beef products markedly enhance α-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 12, 775-783.
7. Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R & Reed SG (2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60, 1677-1682.
8. Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J & Chu PG (2003) Expression of α-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: A study of 761 cases. Hum Pathol 34, 792-796.
9. Jiang Z, Wu CL, Woda BA, et al. (2004) α-Methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology 45, 218-225.
10. Luo J, Zha S, Gage WR, et al. (2002) α-Methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 62, 2220-2226.
11. Nassar A, Amin MB, Sexton DG & Cohen C (2005) Utility of α-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem Mol Morphol 13, 252-255.
12. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D & Chinnaiyan AM (2002) α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287 1662-1670.
13. Witkiewicz AK, Varambally S, Shen R, Mehra R, Sabel MS, Ghosh D, Chinnaiyan AM, Rubin MA & Kleer CG (2005) α-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 14, 1418-1423.
14. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC & Rubin MA (2002) α-Methylacyl-CoA racemase: A novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26, 926-931.
15. Body DR (1977) Characterization of bovine rumen liquor isoprenoid hydrocarbons with reference to dietary phytol. Lipids 12, 204-207.
16. van den Brink DM & Wanders RJ (2006) Phytanic acid: Production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 63, 1752-1765.
17. Riboli E & Kaaks R (1997) The EPIC Project: Rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26, Suppl. 1, S6-S14.
18. Davey GK, Spencer E, Appleby PN, Allen N, Knox K & Key TJ (2003) EPIC-Oxford: Baseline characteristics and nutrient intakes in a cohort of 33,883 meat-eaters and 31,546 non meat-eaters in the UK. Public Health Nutr 6, 259-269.
19. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA & Southgate DAT (1991) McCance and Widdowson's The Composition of Foods, 5th ed. Cambridge, UK: Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Food.
20. Ministry of Agriculture Fisheries and Food (1993) Food Portion Sizes 2nd ed. London: H.M. Stationery Office.
21. Xu J, Thornburg T, Turner AR, et al. (2005) Serum levels of phytanic acid are associated with prostate cancer risk. Prostate 63, 209-214.
22. Vreken P, van Lint AE, Bootsma AH, Overmars H, Wanders RJ & van Gennip AH (1998) Rapid stable isotope dilution analysis of very long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J Chromatogr B Biomed Sci Appl 713, 281-287.
23. ten Brink HJ, Stellaard F, van den Heuvel CM, Kok RM, Schor DS, Wanders RJ & Jakobs C (1992) Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: Stable isotope dilution analysis with electron capture negative ion mass fragmentography. J Lipid Res 33, 41-47.
24. Office for National Statistics (2003) The National Diet and Nutrition Survey Adults Aged 19 to 64 Years. Volume 2: Energy, Protein, Carbohydrate, Fat and Alcohol Intake. London: H.M. Stationery Office. http://www.food.gov.uk/multimedia/pdfs/ndnsv2.pdf
25. Bingham SA, Gill C, Welch A, et al. (1997) Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 26, Suppl. 1, S137-S151.
26. Smedman AE, Gustafsson IB, Berglund LG & Vessby BO (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: Relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69, 22-29.
27. Wolk A, Vessby B, Ljung H & Barrefors P (1998) Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 68, 291-295.
28. Wolk A, Furuheim M & Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131, 828-833.
29. Brevik A, Veierod MB, Drevon CA & Andersen LF (2005) Evaluation of the odd fatty acids 15:0 and 17:0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur J Clin Nutr 59, 1417-1422.
30. Wu Z & Palmquist DL (1991) Synthesis and biohydrogenation of fatty-acids by ruminal microorganisms in vitro. J Dairy Sci 74, 3035-3046.
31. Kumar-Sinha C, Shah RB, Laxman B, et al. (2004) Elevated α-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol 164 787-793.
32. Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM & Isaacs WB (2003) α-Methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 63, 7365-7376.
33. Zheng SL, Chang BL, Faith DA, et al. (2002) Sequence variants of α-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 62, 6485-6488.